NPPA has observed that these devices are important in managing Covid-19 pandemic, not only for home use, but in hospital management too. The National Pharmaceutical Pricing Authority (NPPA) has reported 88% price reduction in one-third of domestic brands of medical devices following trade margin cap at 70% for pulse oximeter, blood pressure monitoring machine, nebuliser, … Read more
Government’s is trying to control the prices of medical devices like pulse oximeter, blood pressure monitoring machine, nebulizer, Indigenous MedTech industry products commercial viability may get adversely impacted by the Government’s move to price control medical devices like pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer by the latter’s trade margin rationalisation … Read more
The manufacturers of these five medical devices selling at price higher than the Maximum Retail Price shall revise the prices downward, not exceeding the MRP computed by using prescribed formula. (Photo source: IE) The National Pharmaceutical Pricing Authority (NPPA) has capped the price of five medical devices namely Pulse Oximeter, Blood Pressure Monitoring Machine, Nebulizer, … Read more